Factors Associated with 60-Day Readmission Following Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy

Introduction Readmission rates following surgery are subject to scrutiny in efforts to control health care costs. This study was designed to define the 60-day readmission rate following cytoreduction and HIPEC at a high-volume center and to identify factors associated with readmission. Methods Patie...

Full description

Saved in:

Bibliographic Details
Published in:	Annals of surgical oncology Vol. 25; no. 1; pp. 91 - 97
Main Authors:	Kelly, Kaitlyn J., Cajas, Luis, Baumgartner, Joel M., Lowy, Andrew M.
Format:	Journal Article
Language:	English
Published:	Cham Springer International Publishing 01.01.2018 Springer Nature B.V
Subjects:	Adult Aged Antineoplastic Agents - administration & dosage Carcinoma - secondary Carcinoma - therapy Chemotherapy Comorbidity Cytoreduction Surgical Procedures - adverse effects Dehydration Dehydration - etiology Female Gastrointestinal Oncology Humans Hyperthermia, Induced - adverse effects Ileus - etiology Infection - etiology Length of Stay Male Medicine Medicine & Public Health Middle Aged Morbidity Oncology Ostomy - adverse effects Patient admissions Patient Readmission - statistics & numerical data Peritoneal Neoplasms - secondary Peritoneal Neoplasms - therapy Postoperative Complications - etiology Pulmonary Embolism - etiology Retrospective Studies Risk Factors Risk groups Surgery Surgical Oncology Venous Thrombosis - etiology Young Adult Cytoreductive Surgery And Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) Control Health Care Costs Deep Space Infection Stoma Creation Peritoneal Carcinomatosis Index (PCI)
ISSN:	1068-9265, 1534-4681, 1534-4681
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!